Intarcia Therapeutics Garners $75,000,000 New Round

  • Feed Type
  • Date
  • Company Name
    Intarcia Therapeutics
  • Mailing Address
    155 Seaport Boulevard 11th Floor Boston, MA 02210 USA
  • Company Description
    Intarcia Therapeutics, Inc., is a rapidly emerging biopharmaceutical company committed to developing innovative therapies that merge medicine with technology, and have the potential to transform therapeutic categories.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The company will use the proceeds to ramp up manufacturing to build inventory for a prospective late 2017 commercial launch.
  • M&A Terms
  • Venture Investor
    Silicon Valley Bank
  • Venture Investor
    MidCap Financial

Trending on Xconomy